Clinical trials
Severe Acute Pancreatitis clinical trials
Below are recruiting severe acute pancreatitis clinical trials, each written for real people, not researchers. We’re tracking 36 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05197920Recruiting
Study of diabetes after acute pancreatitis
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
Los Angeles, CaliforniaAges 18–75 - NCT07439757Recruiting
Using AI to Guide Care for Pancreatic Conditions
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
ShanghaiAges 18–80 - NCT05160506RecruitingPhase 2
Steroids to treat acute pancreatitis in the ICU
This Phase 2 study tests whether corticosteroids (steroid medicines) can improve outcomes for adults with severe acute pancreatitis in the intensive care unit. It’s meant to see if steroids help when the pancreas inflammation is serious.
Boston, MassachusettsAges 18–99 - NCT06401577Recruiting
Acute pancreatitis and diabetes risk study
This study looks at how acute pancreatitis affects blood sugar and the risk of developing diabetes. You'll wear a continuous glucose monitor (CGM) sensor and have metabolic tests to track changes over time.
Los Angeles, CaliforniaAges 18–75 - NCT05451901Recruiting
Direct surgery versus step-by-step drainage for walled pancreatic infection
This study compares two ways to treat a pancreatic infection pocket (walled-off necrosis): removing dead/infected tissue right away versus starting with drainage and escalating if needed. It may help find the safest, most effective approach for getting the infection under control.
Bunkyō-Ku, TokyoAges 18 years+ - NCT03684278RecruitingPhase 2
Infliximab for new acute pancreatitis patients in the first 36 hours
This trial tests infliximab (an anti-inflammatory medicine) versus placebo to see if it improves outcomes in adults with newly diagnosed acute pancreatitis. It is designed for treatment to start within 36 hours of hospital admission.
Aberdeen, AberdeenshireAges 18–85 - NCT07738094Recruiting
Cold and NSAID therapy to prevent post-ERCP pancreatitis
This trial tests if applying cold therapy or giving an NSAID (anti-inflammatory medication) before an ERCP can prevent pancreatitis, a common complication. It is for adults having their first ERCP.
São Paulo, São PauloAges 18 years+ - NCT07681050RecruitingPhase 2
Phosphate for acute pancreatitis
This trial tests if giving phosphate through a vein can help people with acute pancreatitis. It's for adults who come to the emergency room with pancreatitis and can start treatment within 24 hours of being admitted to the hospital.
Durham, North CarolinaAges 18 years+ - NCT07756476Recruiting
Fluid treatment guided by heart response for acute pancreatitis
This study tests whether giving IV fluids based on how your heart responds can improve recovery from acute pancreatitis, compared with usual care. It may help your body handle fluids better during treatment.
Los Angeles, CaliforniaAges 18–75 - NCT04033614Recruiting
Device to help close an open abdomen between surgeries
This study looks at a device (“Fasciotens”) used to help manage an open abdomen and support closure during planned or necessary return surgeries. It aims to see how safely and effectively the device works in people who need a temporary open belly treatment.
Aachen, North Rhine-WestphaliaAges 18 years+ - NCT05294744Recruiting
N-acetylcysteine plus usual care for severe alcoholic hepatitis
This study tests whether adding N-acetylcysteine to standard treatment helps people with severe alcoholic hepatitis. It may improve liver outcomes, especially for those with a high Maddrey score.
Vitoria-Gasteiz, ÁlavaAges 18–75 - NCT05878236Recruiting
Blood and scan markers in acute pancreatitis
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
Los Angeles, CaliforniaAges 18–75
Hear when a new Severe Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for severe acute pancreatitis?
- Yes. Clin2 currently lists 36 recruiting severe acute pancreatitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a severe acute pancreatitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a severe acute pancreatitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.